- Fund Type: Closed-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
H&Q Life Sciences Investors
+ Add to WatchlistHQL:US
18.8600 USD 0.6700 3.43%As of 20:04:03 ET on 05/17/2013.
Snapshot for H&Q Life Sciences Investors (HQL)
| Open: | 19.5700 | High - Low: | 19.6700 - 18.5700 | Primary Exchange: | New York |
|---|---|---|---|---|---|
| Volume: | 126,803 | 52-Week Range: | 12.8600 - 21.0000 | Beta vs NBI: | 0.7901 |
Fund Profile & Information for HQL
H&Q Life Sciences Investors is a diversified, closed-end management investment company incorporated in the USA. The Fund's objective is long-term capital appreciation. The Fund invests mainly in securities of life sciences companies. The Fund invests primarily in securities of public and private companies that are believed to have significant potential for above-average growth.
| Inception Date: | 1992-05-08 | Telephone: | 1-617-772-8500 |
|---|---|---|---|
| Managers: | DANIEL R OMSTEAD | ||
| Web Site: | www.teklacap.com | ||
Fundamentals for HQL
| NAV | (on 2013-05-17) 18.6300 |
|---|---|
| Assets (M) | (on 2013-05-17) 274.0941 |
| Shares out (M) | 14.71 |
| Market Cap (M) | 277.44 |
| % Premium | 1.23 |
| Average 52-Week % Premium | -1.5304 |
| Fund Leveraged | N |
Dividends for HQL
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Quarter |
| Last Dividend Net | (on 2013-05-23) 0.3400 |
| Dividend Yield (ttm) | 6.36% |
Performance for HQL
| 1-Month | +5.36% | 1-Year | +42.68% |
|---|---|---|---|
| 3-Month | +21.64% | 3-Year | +35.85% |
| Year To Date | +32.54% | 5-Year | +18.05% |
| Expense Ratio | 1.72 |
Top Fund Holdings for HQL
Filing Date: 03/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Teva Pharmaceutical Industries | 209,841 | 9,455,436 | 4.546% |
| Celgene Corp | 107,767 | 8,354,098 | 4.017% |
| Alexion Pharmaceuticals Inc | 87,744 | 8,147,908 | 3.918% |
| Gilead Sciences Inc | 326,302 | 7,969,926 | 3.832% |
| Akorn Inc | 580,157 | 6,787,837 | 3.264% |
| Vertex Pharmaceuticals Inc | 161,202 | 6,610,894 | 3.179% |
| Mylan Inc/PA | 279,254 | 6,548,506 | 3.149% |
| Perrigo Co | 60,055 | 6,204,282 | 2.983% |
| Regeneron Pharmaceuticals Inc | 48,995 | 5,713,797 | 2.747% |
| Illumina Inc | 100,700 | 5,297,827 | 2.547% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page